June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Cellular Features of Retinal Pigment Epithelial Atrophy after Regression of Choroidal Neovascularization
Author Affiliations & Notes
  • Mina Chung
    Flaum Eye Institute, University of Rochester, Rochester, NY
    Center for Visual Science, University of Rochester, Rochester, NY
  • Hongxin Song
    Flaum Eye Institute, University of Rochester, Rochester, NY
    Center for Visual Science, University of Rochester, Rochester, NY
  • Lisa Latchney
    Flaum Eye Institute, University of Rochester, Rochester, NY
  • Margaret Folwell
    Center for Visual Science, University of Rochester, Rochester, NY
  • William Fischer
    Flaum Eye Institute, University of Rochester, Rochester, NY
  • Ethan Rossi
    Center for Visual Science, University of Rochester, Rochester, NY
  • Footnotes
    Commercial Relationships Mina Chung, Canon (F); Hongxin Song, Canon (F); Lisa Latchney, None; Margaret Folwell, None; William Fischer, Canon (F), Carl Zeiss Meditec (F); Ethan Rossi, Canon Inc. (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 6284. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mina Chung, Hongxin Song, Lisa Latchney, Margaret Folwell, William Fischer, Ethan Rossi; Cellular Features of Retinal Pigment Epithelial Atrophy after Regression of Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci. 2013;54(15):6284.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Intravitreal injection of anti-VEGF antibodies has proven successful in treating neovascular age-related macular degeneration (AMD). However, some treated patients develop vision loss after regression of choroidal neovascularization (CNV) due to changes in the retinal pigment epithelium (RPE) that clinically resemble geographic atrophy (GA). To understand whether this form of RPE atrophy is distinct from GA, we examine its microscopic features in vivo.

 
Methods
 

An 83-year-old patient with neovascular AMD who developed an atrophic RPE lesion after anti-VEGF injections underwent comprehensive eye examination and conventional imaging including fundus photography and fundus autofluorescence (FAF, Heidelberg Retina Angiograph). Adaptive optics scanning light ophthalmoscopy (AOSLO) was used to image the photoreceptor and RPE cells simultaneously. Near-infrared light (796 nm) was used to image photoreceptors; intrinsic autofluorescence (AF) of lipofuscin was exploited to image RPE cells (excitation 532 nm; emission 650 Δ 150nm), using light levels more than 20 times below the ANSI maximum permissible exposure. Images were obtained within, at the margin, and outside of the lesion area. Two imaging sessions were conducted, three weeks apart.

 
Results
 

AOSLO reflectance imaging within the lesion showed cellular structures of a size and distribution consistent with cone photoreceptors. These cells did not exhibit the temporal variations in reflectivity characteristic of normal healthy cones. Fluorescence AOSLO imaging within the lesion showed collections of AF, not detected by conventional FAF, measuring 20-30 microns in diameter. Hyperautofluorescence was present just outside the lesion margin, and patterns of abnormal AF continued well outside the lesion.

 
Conclusions
 

AOSLO demonstrates that cones appear to be present, but injured, within areas of RPE atrophy after anti-VEGF antibody injections. The sparse collections of AF within the atrophy may represent enlarged, lipofuscin-laden RPE cells. These findings suggest that RPE atrophy developing after anti-VEGF therapy may be distinct from GA.

 
Keywords: 412 age-related macular degeneration • 701 retinal pigment epithelium • 550 imaging/image analysis: clinical  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×